|
Symbol Name ID |
St3gal5
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 MGI:1339963 |
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| St3gal5tm1Rlp/St3gal5tm1Rlp involves: 129S/SvEv * C57BL/6 |
abnormal glucose homeostasis | J:82723 |
| abnormal lipid homeostasis | J:82723 | |
| normal endocrine/exocrine gland phenotype | J:82723 | |
| hypoglycemia | J:82723 | |
| improved glucose tolerance | J:82723 | |
| increased insulin sensitivity | J:82723 | |
| St3gal5tm1Rlp/St3gal5tm1Rlp involves: C57BL/6JJmsSlc |
abnormal cognition | J:171961 |
| abnormal impulsive behavior control | J:171961 | |
| decreased anxiety-related response | J:171961 | |
| hyperactivity | J:171961 | |
| St3gal5tm1Skoz/St3gal5tm1Skoz Not Specified |
abnormal glycosphingolipid level | J:229230 |
| abnormal synaptic glutamate release | J:229230 | |
| abnormal xenobiotic induced morbidity/mortality | J:229230 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 10/07/2025 MGI 6.24 |
|
|
|
||